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ABSTRACT 
White-nose syndrome (WNS) has had a large negative impact on bat populations across eastern 
North America since its arrival in 2006. Bats affected by WNS appear to die of starvation, 
possibly due to the increased arousals during hibernation when there is no food present to replace 
the energy used to arouse. During hibernation, the bat’s immune system should be suppressed. 
However, once a bat of a susceptible species is exposed to the fungus that causes WNS, 
Psuedogymnoascus destructans (Pd), the immune system seems to respond, potentially causing 
an elevation in metabolic rate, which may cause the bat to arouse more often. I hypothesize that 
resistant bats do not mount an immune response; however, if they do mount an immune 
response, I hypothesize that bats inoculated with Pd and treated with an anti-inflammatory 
treatment will not respond to the infection, ultimately preserving fat reserves and lowering 
metabolic expenditures during hibernation. I tested these hypotheses by inoculating a species that 
does not suffer from high WNS mortality (big brown bats: Eptesicus fuscus), with Pd. 
Meloxicam was given to one of the three treatment groups in order to suppress the immune 
system. Metabolic rate during torpor, via oxygen consumption, was measured in addition to 
arousal/torpor bout patterns, the latter utilizing temperature-sensitive dataloggers. To quantify 
expression of four immune-function genes (NLRP10, CD200, ICAM5, and TNFRSF21), gene 
activity was measured via RT-qPCR on tissue and blood samples taken from each bat pre- and 
post- hibernation. These genes were chosen based on a prior study that showed differences in 
these genes between susceptible and resistant species. There were no significant differences 
found across treatment groups for gene expression, nor energetic data; however, hibernation did 
suppress NLRP10 expression, and blood samples consistently had higher gene expression than 
tissue samples, thus indicating these genes may be expressed at low levels in some tissues. It is 
imperative that we continue investigating the differences between susceptible and resistant bat 
species as WNS is advancing westward throughout the country. 
 
KEYWORDS:  immune system, hibernation, torpor, WNS, white-nose syndrome, inflammation, 
Eptesicus fuscus, Pseudogymnoascus destructans, Pd 
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1 
INTRODUCTION 
 
The Order Chiroptera represents more than 1,200 known species of bats that are 
distributed across the globe and demonstrate a wide variety of foraging techniques, diet 
specializations, reproductive behaviors, and habitat diversity (Jones et al. 2005; Kunz et al. 2011; 
Wilson 2019). They account for approximately 20% of all living mammalian species (Hill 1984) 
and include 19 different families. Vespertilionidae, the largest bat family in the world, includes 
over 400 insectivorous bat species. Vespertilionids are well established on all continents except 
Antarctica and hold great physiological diversity (Birkett et al. 2014). The International Union 
for Conservation of Nature (IUCN) reports 7 vespertilionid species critically endangered, 16 
endangered, and 26 vulnerable (IUCN Red List 2019). With the continuous addition of species to 
the threatened list, it is imperative to continue research and educational outreach regarding bats 
and their value, in order to create management plans to aid in the conservation of these animals.  
 
Bat Value 
The natural resources and ecological services that bats provide to our society are 
extremely important. Bats are one of the world’s leading groups of pollinators, and they are 
considered one of the most efficient forms of natural insect control (Kunz et al. 2011). A colony 
of 150 insectivorous bats can consume up to 1.3 million insects per season (Whitaker 1995), 
which saves agriculturalists time and money by not having to treat their crops with 
environmentally un-safe pesticides. Mexican free-tailed bats (Tadarida brasiliensis) are a 
critically important source of natural pest control. A maternity colony of one million bats can 
consume an estimated 8.4 metric tons of insects per night, which is equivalent to one individual 
2 
consuming half of its body weight per night (Kunz and Fenton 2003). It is estimated in the 
United States that insectivorous bats have an economic value of approximately $22.9 billion 
annually in by reducing the need for chemical insect control alone (Boyles et al. 2011). This 
estimation does not include the consumption of forest pests, which aid harvesters of lumber, nor 
does it include the human health aspects of avoiding the ingestion of potentially harmful 
pesticides or a decrease in insect-borne diseases. Therefore, the estimate of the economic 
importance of bats is clearly an underestimate. 
In Mexico, Agave tequilana, the plant from which we derive tequila, was known to have 
a very small genetic diversity in cultivated fields, leaving them vulnerable to disease that may 
lead to widespread crop failure. With the help of bat pollination, and bat-friendly agricultural 
practices, genetic diversity has been increased (Trejo-Salazar et al. 2016). At one Agave farm, 
progressive Agave farmers are allowing 5% of their crops to flower, which feeds an estimated 89 
individual bats per night (Trejo-Salazer et al. 2016). In addition to providing bats food, 
pollination as a result of bat nectar consumption has increased genetic diversity via pollination of 
Agave flowers throughout many Agave croplands across Mexico (Trejo-Salazer et al. 2016). An 
increase in genetic diversity is not only beneficial to the fitness of the species, but also acts as a 
form of job security for many Agave farmers in Mexico’s rural areas, since their entire crop is 
less likely to be killed by an emerging disease or climate change issues. If this practice was 
implemented across Mexico, it could provide food for over two million bats per month across the 
country during the flowering season, in addition to aiding in economic growth (Trejo-Salazer et 
al. 2016). 
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Conservation Implications 
Fungal diseases have had a devastating impact on multiple taxa, both plant and animal, 
across the globe. The increase in fungal pathogens are due to both environmental and non-
environmental factors. Global warming is an environmental factor that is allowing fungi to 
flourish in areas that were not well-suited habitats several years ago. Because the majority of 
fungi are typically found in moist, temperate environments, the warming of the earth and the 
change in habitats are allowing fungal pathogens to inhabit new areas, which means they could 
be inhabiting new hosts (Konkel 2017). These shifts in temperature could drive the evolution of 
more heat-tolerant fungal pathogens (Konkel 2017). In addition, drug resistance has also been a 
factor in increasing fungal pathogens. A large amount of agricultural fungicides are no longer 
providing protection against fungal pathogens due to increased resistance (Konkel 2017). These 
fungal pathogens have been devastating to several populations and are increasingly becoming 
more virulent (Konkel 2017). 
A fungi, known as rice blast (Magnaporthe oryzae), can cause losses of up to 30% of a 
grain field in a given season (Talbot 2003), which can inhibit agricultural yield and disrupt the 
ecological balance of the area. Among animal taxa, frog (McCallum 2005), bee (Fisher et al. 
2012), and bat (Blehert et al. 2009) populations have all been declining due to invasive fungal 
diseases that affect the animals’ environment and immune systems. Chytrid fungus in 
amphibians has decimated populations globally. This fungus infects keratinized cells of the 
epidermis, but the mechanism of how this fungus becomes fatal is unknown (Ouellet et al. 2005). 
Chalkbrood is a fungal disease in bee populations that affects the developing broods (Flores et al. 
2005). It causes mummification of the infected individual, causing population declines and 
decreased honey production. In social animals such as bees, individual and social immune 
4 
responses may be produced to create a warning to other colony members (Armitage et al. 2011). 
Physiological, organizational, and behavioral defenses allow colonies to form social immunity 
by preventing attack and dispersal of pathogenic agents (Richter et al. 2012). Bats also face a 
high risk of contracting a fungal disease known as white-nose syndrome (WNS).   
Bat populations of some species in North America have been declining rapidly for 
several decades. Habitat destruction (Rabinowitz and Tuttle 1980; Medellin 2003), wind energy 
farms (Arnett et al. 2008), and WNS (Blehert et al. 2009) are the primary causes for this decline. 
Bats typically select specialized habitats for foraging and roosting, such as caves and mines 
(Brooks and Ford 2006); however, due to cave and mine destruction for agriculture and 
development, populations that previously inhabited these areas are displaced. They then select 
areas to roost where they are seen as pests and/or are being forced to roost in areas of increased 
vulnerability to predators (Mering and Chambers 2014).  However, scientists and civilians are 
now creating artificial roosts, where natural roosts have been destroyed, to aid in population 
management and to increase bat-mediated seed dispersal and pest control (Mering and Chambers 
2014). In addition, bat mortalities have now surpassed bird mortalities in regions where wind 
turbines are abundant (Barclay et al. 2007). An estimated 1.3 million bats were killed by wind 
turbines from 2000-2012 (Arnett and Baerwald 2013). While conservationists and 
environmentalists are advocating for renewable energy resources to take over as primary energy 
sources, they are also fighting to reduce bird and bat mortalities by implementing new strategies 
to help these animals avoid the areas and to engineer safer designs for wind turbines (Baerwald 
et al. 2009; Zimmerling and Francis 2016). In addition, WNS has been the leading cause of bat 
population decline since its arrival in the US in 2006 (Blehert et al. 2009). Some species have 
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suffered from exceedingly high rates of mortality (90-99%) in several populations across eastern 
North America (Blehert et al. 2009).  
 
WNS and Big Brown Bats 
The responsible pathogenic agent of WNS is Pseudogymnoascus destructans (Pd) (Field 
et al. 2015), previously referred to as Geomyces destructans (Lorch et al. 2011). Pd is a 
psychrophilic (cold-loving) fungal pathogen that poses physiological threats such as increased 
frequency of arousal and resulting depletion of fat during the hibernation season (Verant et al. 
2014). The fungus was first observed at Howe’s Cave, New York in 2006 (Blehert et al. 2009) 
and has since spread westward throughout the eastern and central United States and Canada, and 
reaching small, isolated sections of California and Washington state (Lorch et al. 2016; Fig. 1). 
The presence of Pd has been observed on 18 species of bats in North America: eastern small-
footed bats (Myotis leibii), Indiana bats (M. sodalis), gray bats (M. grisescens), little brown bats 
(M. lucifugus), northern long-eared bats (M. septentrionalis), southeastern myotis (M. 
austroriparius), Yuma myotis (M. yumanensis), big brown bat (Eptesicus fuscus), cave myotis 
(Myotis velifer), silver-haired bat (Lasionycteris noctivagans), Virginia big-eared bat 
(Corynorhinus townsendii virgianus), eastern red bat (Lasiurus borealis), Rafinesque’s big-eared 
bat (Corynorhinus rafinesquii), Ozark big-eared bat (Plecotus towndendii ingens), Townsend’s 
big-eared bat (Corynorhinus townsendii), western small-footed bat (Myotis ciliolabrum), 
Mexican free-tailed bat (Tadarida brasiliensis), and tri-colored bat (Perimyotis subflavus) 
(Moore et al. 2013; Bat Conservation International 2018). Although Pd spores and/or hyphae 
have been observed in these species, it is not always an indication of inevitable mortality. Some 
species are relatively resistant to WNS, while others are known to be extremely susceptible 
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(Davy et al. 2017). It has been suggested that bat populations in Europe most likely coevolved 
with G. destructans, enabling resistance to the fungus via residual microbes (Wibbelt et al. 
2010). European populations have had relatively little-known mortality compared to populations 
in North America. Pd has also been found in several sites in northeastern China, as well as in 
high rates throughout Russia (Hoyt et al. 2016; Kovacova et al. 2018), without any mass 
mortality events documented. In addition to questioning the genetic differences between 
European bat populations and North American populations, this also raises the question of how 
WNS is being transmitted between land masses. Marine vessels have been a vehicle of assisted 
migration of bats to Alaska and Canada (Voute 1980; Wright and Moran 2011). Furthermore, 
human-assisted spread of Pd has contributed to the rapid dispersal of the fungus to and within 
North America. The lack of decontamination efforts by cavers have likely increased the speed 
and range of fungal spread (Ballmann et al. 2017). 
Pd grows at temperatures between 2-18C (Verant et al. 2012), with an optimal growth 
temperature of 5-10C (Blehert et al. 2009), which coincides with typical ambient temperatures 
of bat hibernacula. When fungal spores germinate, they develop into filaments of fungal cells, 
called hyphae, that become embedded in the epidermis of the hibernating bat skin. The hyphae 
become a large network, which then extends under the skin surface, leading to the generation of 
white fruiting bodies on the cutaneous membranes (skin) of the face and wings of the bats 
(Boyles and Willis 2010), causing microscopic erosions in tissue that serves as a quantitative 
index of disease severity (Reeder et al. 2012). Symptoms of the syndrome include an increased 
number or arousals (Reeder et al. 2012), low fat reserves (Britzke et al. 2010; Courtin et al. 
2010), increased evaporative water loss (Willis et al. 2011), and increased metabolic rate 
(Anderson 2018; McGuire et al. 2017). Pd can also be spread through bat-to-bat or environment-
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to-bat contact within and between hibernacula (Meyer et al. 2016); additionally, ectoparasitic 
Spinturnix mites, are found exclusively on bat wings and have tested positive for Pd, suggesting 
an additional mode of transmission as mites travel from bat-to-bat (Lučan et al. 2016).   
Big brown bats have suffered relatively little mortality since the arrival of WNS in North 
America (Langwig et al. 2012). In sites that have been previously exposed to Pd, big brown bat 
populations remain stable, whereas little brown bat populations have declined dramatically 
(Frank et al. 2014). Little brown bats suffer from more severe membrane lesions compared to big 
brown bats (Moore et al. 2018). Big brown bats have a body mass of 11-25 grams (Kurta and 
Baker 1990) and have a wide geographical range, spanning from northern Canada to Mexico 
(Parker et al. 1997). In the northern part of their range, these bats typically hibernate in 
extremely cold microclimates, not only in caves and mines, but also in tree holes, rock crevices, 
and man-made structures. Big brown bats typically arouse more often than little brown myotis 
during the hibernation period, with torpor bouts lasting 3.3 ± 13.3 days (Halsall et al. 2012) and 
20.88 ± 6.22 days (Jonasson and Willis 2012; Ehlman et al. 2013), respectively. This could 
explain why severe population declines have not occurred in big brown bats (Turner et al. 2011; 
Frank et al. 2014), suggesting more euthermic periods could aid in fighting WNS. However, this 
has never been tested in whole bats, only in wing tissue (Field et al. 2015). Big brown bats’ 
arousal frequencies do not seem to be influenced by Pd presence (Moore et al. 2018).  
Besides a differing immune response, another factor that might provide protection from 
WNS is the fatty acid composition on skin membranes. E. fuscus have higher amounts 
(compared to M. lucifugus) of myristic, palmitoleic, and oleic acids (fatty acids present on 
cutaneous membranes) that inhibit the growth of Pd in vitro (Frank et al. 2016). It has been 
suggested that fatty acids on the skin are providing protection against membrane deterioration, 
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creating a barrier that doesn’t allow the pathogen to infiltrate the tissue (Ingala et al. 2017), and 
requiring little or no immune response to the fungus. A third factor that might confer WNS 
resistance is the skin microbial community. Microbes such as Pseudomonas have also been 
shown to act as a probiotic on in vitro bat skin that may outcompete Pd (Hoyt et al. 2015). Due 
to big brown bats being relatively resistant to WNS, they have received less attention, and little is 
known about how their immune system might actually respond to Pd. 
 
Hibernation 
During hibernation, mammals go through periods of torpor, which consist of a controlled 
decrease of body temperature (Tb) and associated physical inactivity (Carey et al. 2003). Bats are 
heterotherms that can reduce Tb to save energy (Dunbar and Tomasi 2006). Their hibernation 
seasons usually consist of long bouts of torpor (10-20 days) separated by brief arousals that last 
2-3 hours (Spurrier and Dawe 1973; Lyman et al. 1982; Fig. 2). During an arousal, the animal’s 
metabolism increases, heightening Tb (Day and Tomasi 2014) and causing bats to utilize stored 
fat reserves. Thus, with more arousals, the fat reserves are depleted more quickly. Mitochondria 
in brown adipose tissue utilize a modified electron transport chain in order to produce heat to 
raise the Tb during an arousal. In addition, the ATP generated from glycolysis, oxidative 
phosphorylation, and lipid catabolism are utilized to increase oxygen consumption and Tb. In a 
population of healthy bats, individuals will typically go through seasonal and sexual variation in 
metabolism and thermoregulation. Females will gain more weight prior to hibernation to ensure 
some energy is available for reproduction the following spring (Richardson et al. 2018). To 
conserve energy, bats at the end of hibernation appear to use barometric pressure within the 
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hibernacula to predict the weather and associated changes in abundance of insects outside of the 
roost without having to investigate first-hand (Paige 1995).  
Similar to the decreased rate of other physiological processes during hibernation, the 
immune system is often suppressed. The production of antibodies (McKenna and Musacchia 
1968) and the lipopolysaccharide (LPS) response are generally limited in most hibernating 
animals (Maniero 2000; Prendergast et al. 2002). Animals infected with psychrophilic bacteria 
during hibernation could have an increased risk of severe infection due to the lack of an immune 
response (Luis and Hudson 2006). Arousals may be an opportunity to fight off pathogens due to 
the suppression of the immune system while in torpor. Therefore, both immune function and the 
thermogenesis of arousals may contribute to the depletion of energy reserves (Canale and Henry 
2011).  
 
Immune Function 
In response to a pathogen invasion, the immune system will initiate immune defenses, 
beginning with cell signaling and resulting in phagocytosis and destruction of the pathogen 
(Shoman and Levitz 2005; Blanco and Garcia 2008). The initial response against a pathogen is 
formed by the “innate” immune system, which is always present and responsive. The innate 
immune system is responsible for the detection and defense against “non-self” pathogens by 
recognition of the proteins and surface molecules of foreign biota. Once the immune system 
detects a pathogen, it will begin its defense by secreting chemical messengers to attract 
leukocytes (white blood cells), such as macrophages and neutrophils, to the site of infection. 
These leukocytes are crucial to the production of cytokines, which are more proteins released for 
cell-to-cell communication during immune responses. Pro-inflammatory cytokines will recruit 
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other nearby leukocytes, which intensifies the immune response and upregulates specific genes, 
such as NLRP10 or CD200 (defined below).  
At this time, the “adaptive” immune system will usually start producing antibodies 
against the pathogen. These antibodies can remain present for several years in the body and can 
continue to fight off the pathogen during subsequent exposures. In little brown bats, anti-Pd 
antibodies have been observed, which suggests that antibody-mediated responses to Pd may not 
provide adequate protection against WNS (Johnson et al. 2015).  
In order to bolster our knowledge of how the immune system responds against Pd, it is 
important to explore all viable options, and distinguish between competing hypotheses. Some 
species suffer extensive mortality due to WNS, while others appear to be resistant. In spite of the 
immune system being suppressed during torpor and hibernation, a partial (albeit insufficient) 
immune response to Pd exposure may still occur in at least little brown bats (Moore et al. 2013). 
This elevates torpid metabolism (Janicki 2010; McGuire et al. 2017), possibly causing the 
observed increase in arousals (Reeder et al. 2012). WNS mortality seems to stem from 
emaciation (Britzke et al. 2010), which may be due to the increased energetic cost during torpor 
and the increased number of arousals.  
Differences in WNS mortality could be explained by variations in the immune response. 
One possible explanation for WNS mortality is that, upon exposure to Pd, the immune system of 
susceptible bat species initiates an inflammatory response, increasing energy expenditures during 
hibernation, leading to a depletion of previously stored fat reserves. However, the immune 
response is not sufficient to rid the bat of the fungus and thus the immune response is indirectly 
detrimental to the survival of the bat. In a susceptible species, this suggests that an anti-
inflammatory treatment, such as meloxicam (mel), would suppress the immune response, 
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allowing the bats to preserve fat reserves instead of arousing to fight off a pathogen. If a WNS-
resistant species, such as big brown bats, are surviving the WNS epidemic because they do not 
try to mount an immune response, it is expected that an anti-inflammatory treatment will have no 
effect on them. Susceptible bats have been shown to differentially express immune-function 
genes, in response to Pd, which resistant species do not (Anderson 2018). That study was 
conducted via cell culture analysis through transcriptomics and was used to identify the specific 
genes I have selected. Investigating the immune function of resistant bats will aid in 
understanding the distinction between resistant and susceptible bat immune responses. 
 
Research Questions 
I focused on the following metabolic and immune regulatory genes to understand how the 
immune system in big brown bats responds to Pd exposure during hibernation. These genes are:  
• NOD-like receptor family pyrin-10 (NLRP10) – This gene plays a key role in the 
innate immune system. In addition, it has been suggested that this gene is also a 
negative regulator of inflammation and cellular apoptosis. It has also been implicated 
in the immune response to fungal infection in mice. 
 
• Intercellular adhesion molecule 5 (ICAM5) – This adhesion gene is crucial to the 
immune-nervous system interactions during an infection. It is known to bind to 
leukocytes during inflammation and immune responses. 
 
• Cluster of differentiation 200 (CD200) – This gene plays a role in 
immunosuppression and anti-tumor activity. It is distributed across the cell surface as 
a glycoprotein, which can interact with receptors and mediate the immune response. 
 
• Tumor necrosis factor receptor superfamily member 21 (TNFRSF21) – This gene 
plays a role in T-helper cell activation, which is directly related to immune response. 
 
In summary, all of these genes play an essential role for both the innate and adaptive 
immune system (National Center for Biotechnology Information Database). Differential 
expression of these genes will indicate whether the bats are activating their immune system. I 
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hypothesized that because big brown bats are relatively resistant to WNS, exposure to Pd would 
not change the expression of these genes. Consistent with the belief that resistance is due to a 
lack of an immune response, I further hypothesized that inoculated bats of a WNS-resistant 
species treated with meloxicam would not express differences in gene regulation compared to the 
Pd-inoculated group. Gene expression was measured via RT-qPCR from wing and blood tissue 
taken during initiation and termination of this experiment.  
In addition to gene expression, measurements of metabolic rate and Tb were made to 
evaluate differences in arousals and torpor duration among treatment groups. Due to the WNS-
resistant nature of this species, I hypothesized that bats exposed to Pd would not display any 
differences in torpor/arousal patterns. Furthermore, I hypothesized that the Pd-inoculated bats 
treated with the anti-inflammatory drug would also not display any differences from inoculated 
bats without the anti-inflammatory agent. To test these hypotheses, torpor duration, arousal 
cycles, and O2 consumption were measured in Pd-exposed big brown bats with and without the 
meloxicam, the anti-inflammatory agent, and compared to control bats. 
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METHODS 
 
In January 2018, 30 male hibernating big brown bats were collected by hand from a Pd-
positive mine hibernaculum in Unity Village, Missouri. Bats were transported in sterilized cloth 
bags to Missouri State University where they were weighed and assigned to treatment groups. 
Capture of these bats was permitted by the Missouri Department of Conservation (permit #17622 
to Thomas Tomasi). All animal welfare and care techniques were approved through the Missouri 
State University Institutional Animal Care and Use Committee (IACUC) under protocol 18.017.  
All bats were tested for Pd presence on their muzzle, ears, and wing membrane using a 
sterile swab. All swabs were stored at -80C until PCR according to the DreamTaq polymerase 
protocol by ThermoFisher Scientific (cat. no. K1072; Lot: LT-02241) could be completed. 
Following PCR with the use of Pd primers (Table 1), swab samples were then evaluated via 
agarose gel using ethidium bromide to verify the presence of the Pd sequence. Results of this 
PCR demonstrated that all bats tested negative for Pd at the beginning of the study. 
The bats were randomly assigned into three treatment groups (n=10 per treatment) and 
placed in environmental chambers maintained at 8C, 85% relative humidity, and 0L:24D photo 
period until April 2018, the end of their natural hibernation season. Water was added to a glass 
dish at the bottom of each chamber when needed. In order to observe the bats without 
disturbance, IR cameras were positioned inside each environmental chamber. Cameras were 
checked twice daily to ensure any apparently dead or distressed bats were removed in a timely 
manner.  
Pd spores were placed along the lateral aspect of the body, on the wing margins of bats in 
the two treatment groups. The first treatment group was inoculated with 1x105 CFUs (colony 
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forming units) of Pd, plus 2.5 µg meloxicam in 25 µL dimethyl sulfoxide (DMSO) on the 
posterior side of the ears. This is approximately 0.15 µg/g bat, a veterinarian-recommended 
effective anti-inflammatory concentration for topical use (M. Stafford, personal communication). 
The second treatment group received the same inoculation of Pd, plus 25 µL DMSO (vehicle 
control) along the posterior aspect of the ears. The final treatment group served as a control (i.e. 
no Pd inoculation, DMSO, or meloxicam). Subsequent dosing of 25µL DMSO (vehicle) or 
meloxicam occurred approximately every two weeks, on the posterior aspect of the ears, until 
hibernation ended.  Because meloxicam has been shown to inhibit biofilm formation of other 
fungal species (Alem and Douglas 2004), a preliminary test was conducted to determine which 
meloxicam dose would directly inhibit Pd growth (Anderson 2018). In that study, 0.10 µg/mL 
showed no fungal inhibition (in the in vitro growth medium).  It should be noted however, that 
the effect of torpor on the dosage/metabolism of meloxicam has not been previously studied.  
Temperature-sensitive dataloggers (AlphaMach iButtonsTM; DS2422), modified to reduce 
mass (Lovegrove 2009), were set to record temperature (to 0.5ºC) every 20 minutes and were 
attached to the back of each bat using surgical cement to identify torpor/arousal cycles 
throughout winter.  
During the middle (8 January 2018) and end (15 March 2018) of the hibernation season, 
metabolic rates while torpid were calculated as a rate of O2 consumption. These measurements 
were conducted in 50 mL open-flow metabolic chambers. Chambers were lined with plastic 
mesh to provide a surface for attachment for the bat and were placed in a small refrigerator that 
was maintained at 8  2C. Continuous air flow through each metabolic chamber was achieved 
by an air pump when the bat’s metabolism was not being measured. During metabolic rate 
measurements, air was pulled through these chambers via a flow controller maintained at 
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25mL/min (Sable Systems). Soda lime and silica gel removed carbon dioxide and water, 
respectively, prior to passing through the oxygen analyzer (Sable Systems, FC-10a) with room 
air set as 20.95% oxygen. All bats were acclimated to the metabolic chamber for at least 12 
hours prior to measurements to ensure torpor was established. ExpeDataTM was used to sample 
the excurrent percent oxygen every second until at least three full apneic/breathing cycles were 
recorded (Fig. 3).  
Dataloggers were removed from each bat post-euthanasia or prior to release, and 
temperature data were analyzed for arousal bouts. Arousals were defined as any three 
consecutive (equaling one hour) temperature recordings above 15C. To obtain metabolic rates 
for each bat (displayed as mL O2/hr), the sum volume (mL) oxygen consumed per breathing 
cycle was divided by the total time (hours) of each cycle. O2 consumption data from mid- and 
late- hibernation were averaged to obtain one value per bat. Arousal durations were measured as 
the total amount of time (minutes) above 15C. Arousals that correspond to the disturbance of 
opening the chamber for bat removal were not included.  
Ultraviolet (UV) light photographs were taken to identify the presence of any Pd growth 
on each wing membrane at the beginning (day 0) and end (day 77) of the study. Photo analyses 
were completed using ImageJ software (Rasband 1997-2018). The percentage of area infected 
was computed by outlining the area (pixels) of the whole bat, then determining the percent of 
area infected by outlining the area (pixels) of the fluoresced/infected regions of the bat wing 
membrane.  
Wing tissue biopsies (3-mm diameter) and blood samples (~20-50µL via femoral vein) 
were also taken from the bats upon capture to establish the baseline immune function, and upon 
completion, to measure differentially expressed genes. All samples were stored at -80C. 
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Surviving bats in the control treatment were released at the site of capture in early April after one 
week of feeding and monitoring. All other bats were then euthanized to avoid releasing Pd-
exposed bats into the wild. Survival rates were calculated as the number of days alive from point 
of capture to point of experiment termination (77 days). 
Blood and tissue samples were analyzed for gene expression of NLRP10, CD200, 
ICAM5, and TNFRSF21 via RT-qPCR according to the manufacturer’s protocol (DyNAmo HS 
SYBR Green: ThermoFisher Scientific; cat. no. F410L; lot: 00672146) following RNA isolation 
using TRIzol (Invitrogen; cat. no. AM97381). Primers for the genes of interest were created 
based on transcriptomics data (Anderson 2018) via CLC Genomics Workbench. The annealing 
temperatures were confirmed via PCR and gel electrophoresis (Table 1) and used under the 
following thermal cycler conditions: three minutes of primary denaturation (95C), 40 cycles of 
denaturation (30 seconds at 95C), annealing (30 seconds at the specified temperature per Table 
1), and extension (1 minute at 72C), with a final extension step (10 minutes at 72C).  
Gene expression was determined by the CT method based on the number of PCR 
cycles compared to a standard curve. I did a linear regression of the cycle threshold values from 
the standards. This line was then used to interpolate the number of copies of RNA for each 
individual bat sample. The four genes of interest for each sample were also normalized against 
the expression of RPS8 (ribosomal protein subunit 8) after determining the RPS8 expression by 
the CT method based on the number of PCR cycles compared to its own standard curve. This 
was completed to eliminate any differences in RNA concentration due to variability of RNA 
extraction efficiency or sample handling. The normalized data were then log10 transformed to 
minimize the data distribution. RNA concentrations below the level of detection were assigned a 
relative value of 0.01 (log10 = -2.00). 
17 
Treatment effects on rates of oxygen consumption, total arousal time (hr), number of 
arousals, and total mass loss (g) were tested via one-way analyses of variance (ANOVAs). 
Because the control bats were not exposed to the fungus, the effect of meloxicam was assessed 
by comparing the Pd-inoculated bats to the Pd + mel bats, via ANOVA, and infection severity 
was assessed via UV photos. Survival rates were analyzed via a Log-rank test. Quantitative gene 
expression (relative number of RNA copies) between treatment groups were analyzed via one-
way ANOVA and Tukey’s post-hoc test when the ANOVA was significant.  Comparisons of 
tissue type (blood vs. wing tissue) and hibernation duration (January vs. March) were also made 
with two-sample T-tests. Significance was established at  = 0.05. Statistical analyses were 
performed using Minitab 18. Data are presented as mean  SE. 
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RESULTS 
 
Data from temperature-sensitive dataloggers (Fig. 4; Table 2) were analyzed for 28 bats 
throughout the hibernation study and were compared among treatment groups; two bats did not 
wear dataloggers due to equipment limitations. We should note that some dataloggers failed to 
communicate with the software/hardware post-experiment, mostly in the Pd + mel treatment, 
which reduced the sample size for this treatment to 5 bats.  
 The number of arousals did not differ among the treatment groups (p = 0.340). 
Consistent with the number of total arousals, the average total arousal duration did not differ 
among treatments (p = 0.395). O2 consumption (mL/min) also did not differ significantly among 
treatment groups (p = 0.089), though Pd + mel bats did trend toward a higher average O2 
consumption than Pd bats or control bats (Fig. 4; Table 2). On average, mass loss did not differ 
between treatments (p = 0.145; Fig. 4; Table 2). Overall, across all groups, mass loss (%) did not 
change with number of arousals (p = 0.820; Fig. 5). There was no relationship between torpid O2 
consumption and number of arousals (p = 0.104).  
UV analyses of infected wing area revealed no differences between treatments (Table 2). 
The survival rates, through the 77 days of the study, for the control, Pd, and Pd + mel bats were 
80%, 70%, and 50%, respectively (Fig. 6; Table 2). 
Based upon gene expression data, the random assignment of bats was successful; 7 of 8 
of the measures in January (blood and wing samples), showed no difference between treatment 
groups. However, CD200 January wing samples did show a difference between treatment groups 
prior to treatment initiation (Table 3; Figs. 7-10). Bats in the control treatment showed a decrease 
in gene expression from January to March in NLRP10 (p < 0.0005) and CD200 (p < 0.0005), but 
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not in ICAM5 (p = 0.085) or TNFRSF21 (p = 0.585). When all genes and treatments are 
combined, expression is lower in March than in January (p < 0.0005). 
To address the question of any Pd effect on gene expression, I compared January (pre-
Pd) to March (post-Pd) wing samples, which showed no difference in the expression of any 
genes of interest (Table 4). Similarly, in March, gene expression was not different in Pd bats 
compared to controls (Table 4). To address the question of whether mel alters gene expression of 
bats exposed to Pd, I compared January (pre-treatment) to March (post-treatment) bat samples, 
which only revealed a difference in NLRP10 expression (Table 4). Gene expression in Pd + mel 
bats did not differ from expression in Pd bats (Table 4). Expression across all treatment groups 
in March did not differ throughout any genes of interest (Table 3). I also found that gene 
expression was higher in blood than in wing samples (Table 3; p  0.001 for all four genes).   
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DISCUSSION 
 
The results from the energetics section of this study support the hypotheses that neither 
Pd inoculation, nor an anti-inflammatory agent, would cause differences in WNS symptoms, 
such as arousal duration or O2 consumption, in big brown bats. Meloxicam bats trended toward 
more mass loss, more time aroused (number of arousals, and longer arousal duration), and higher 
metabolic rates in torpor, which together suggest that meloxicam may harm the bats. However, 
individually, these parameters did not differ between treatments and there is no direct evidence 
that meloxicam effected mortality.  
Bats inoculated with Pd (with or without meloxicam) demonstrated severe damage to the 
wing membrane, which is typically observed in susceptible species like little brown bats 
(Meteyer et al. 2009). This level of severity has not been observed in Pd-exposed big brown bats. 
While the infection severity was higher in meloxicam bats, the survival rates among treatment 
groups did not differ significantly.  
The control bats were not infected with Pd, but their expression levels for all genes of 
interest still decreased with time, indicating that expression was inhibited by hibernation 
progression, not the Pd infection. This could occur if, for example, the suppression of gene 
expression was based on levels of body fat.  An additional variable could be the physiological 
state of the bats when samples were collected. Bats were aroused for several hours prior to first 
sample collection (January), during transport from their hibernation site to the laboratory, 
whereas bats were fairly torpid during second sample collection (March). This is consistent with 
the findings that immunosuppression takes place during torpor bouts (McKenna and Musacchia 
1968; Luis and Hudson 2006). Another possible explanation is that RPS8 (normalizing gene) 
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increased as hibernation progressed, but this seems unlikely due to the physiological depression 
that occurs during torpor. In addition, gene expression of RPS8 is consistent across multiple 
tissue types in euthermic birds (Carvalho et al. 2019), but this has not been tested during torpor. 
January samples were taken prior to exposure to Pd, which may indicate that these bats express 
these genes at low levels consistently. 
Expression of CD200 in January wing samples was different across treatment groups, 
which posed a peculiar question of why there would be any difference prior to Pd exposure, but 
no significant difference post-exposure in March. The cause of this significant difference is 
unknown and could be a Type II statistical error.  
Gene expression was higher in January blood samples than in January and March wing 
samples. This is likely due to the density of leukocytes (cells with nuclei), and thus active 
immune system genes, in the blood compared to other types of tissues, which contain a larger 
variety of cell types. A dilution effect takes place when these immune system cells, such as 
macrophages, are mixed with other cells, such as normal epithelial cells, in skin tissue that do not 
participate in immune system function.  
Other than CD200 in January wing samples, all other gene expression findings support 
my hypothesis. Due to the WNS-resistance of big brown bats, I hypothesized there would not be 
significant differences in gene expression across treatment groups. Instead of upregulating 
immune genes, their immune systems would remain downregulated, as typically observed during 
hibernation. The combination of infection severity, observed by UV photos, and the scarcity of 
gene expression differences among treatment groups supports my hypothesis that big brown bats 
do not seem to mount an immune response during hibernation when exposed to Pd.  
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Limitations to this study include a limited sample size due to collecting permit limitations 
based on conservation measures. In addition, the refrigerator that housed the metabolic chambers 
displayed a +2C shift from the desired temperature, and this range of 4C may have affected the 
measured metabolic rates of these bats. Statistical analyses for gene expression may have yielded 
some differences if March blood samples were also included. Without March blood samples, 
meloxicam’s influence on the ability to mount an immune response was based solely on wing 
tissue gene expression data. Blood samples were taken in March, but extremely low RNA 
concentration levels after extraction prevented these samples from being utilized. As 
conservation constraints should remain present, it is apparent that blood provides an accurate 
representation of gene expression; however, wing tissue sampling should be considered as it 
seems less invasive. 
Since the debut of WNS in North America in 2006, an estimated 5.7–6.7 million bats had 
died by 2012 (USFWS 2012), with a likely additional 6 million bats dying in the next 6-year 
period (2012–18). As WNS continues to spread west, it is important to understand the 
physiological and genetic differences between resistant and susceptible species. If there is an 
understanding of how resistant species are maintaining their vigilance against Pd, there is 
potential for both increasing the resistance of susceptible species and identifying the 
susceptibility of western bat populations before the fungus presents itself in those areas. While it 
is imperative to implement additional conservation measures, such as caving regulations and 
educational awareness, it is also crucial that we continue investigating the differences between 
susceptible and resistant bat species as WNS is advancing westward throughout the North 
American continent.  
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Table 1. Primer sequences for all primers used in this study were based on prior transcriptomics 
data (Anderson 2018). Primers were originally tested via PCR and then analyzed on an agarose 
gel using ethidium bromide.  
 
 
Primer Primer Sequence 
Annealing  
Temperature (C) 
NLRP10 forward GACATCTTCATGGCCTACGTC 53 
NLRP10 reverse CGGAAGCTGTAGAACTTCTTGATG 53 
CD200 forward GAGCTGGGACTTCAGAACACAACC 55 
CD200 reverse TTCCTGACCCAGCGACCTTCCAG 55 
ICAM5 forward GCACCGCGGCCAATGTCCAG 53 
ICAM5 reverse GGGGCCATATTCCACCGTGATGG 53 
TNFRSF21 forward AATGCTACCTGCGCTCCCCATA 55 
TNFRSF21 reverse TCATTGATGTCAAAATGCTTGTGCG 55 
RS8 forward CTCGGGACAACTGGCACAAG 57 
RS8 reverse TCAGCTTGGCCCCCTTCTTGC 57 
Pd forward CTTTGTTTATTACACTTTGTTGCTTT 67 
Pd reverse CCGTTGTTGAAAGTTTTAACTATTATAT  67 
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Table 2. Energetics data from big brown bats during hibernation, inoculated with Pd, with or 
without meloxicam (anti-inflammatory). P-values are based on a one-way analysis of variance 
(ANOVA). Data are presented as mean  SE (n). 
 
 
Parameter Control Pd Pd + mel P-value 
Mass loss (g) 3.08  0.26 (9) 3.42  0.28 (9) 4.17  0.64 (10) 0.145 
# of arousals 6.40  0.51 (5) 8.10  0.82 (9) 8.40  0.92 (10) 0.340 
Avg. arousal duration (hr) 15.40  1.90 (5) 13.26  1.59 (9) 21.77  6.41 (10) 0.395 
O2 consumption (mL/min) 0.004  0.00 (5) 0.004  0.00 (7) 0.01  0.01 (4) 0.089 
Avg. infection score (%)  17 ± 2 (7) 23 ± 6 (7) 0.357 
Avg. study survival (days) 76.2 ± 0.6 (10) 74.7 ± 1.5 (10) 75.9 ± 0.5 (10) 0.513 
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Table 3. Descriptive statistics and p-values for treatment differences for all genes of interest. All 
treatment groups were tested against each other within each parameter for all four genes. P-
values are based on a one-way analysis of variance (ANOVA). Data are presented as the log10 
mean  SE (n). The asterisk indicates statistical significance (p < 0.05). 
 
 
Parameters Control Pd Pd + mel P-Value 
NLRP10     
January Blood 2.420  0.159 (10) 2.624  0.124 (9) 2.479  0.224 (7) 0.658 
January Wing 1.595  0.328 (7) 0.762  0.606 (6) 1.965  0.419 (5)  0.217 
March Wing -1.634  0.281 (7) -0.641  0.621 (5) -1.722  0.237 (4) 0.173 
CD200     
January Blood 0.766  0.341 (10) 1.436  0.146 (9) 0.930  0.524 (7) 0.413 
January Wing 0.651  0.346 (7)  -1.170  0.534 (6) 0.393  0.685 (5) *0.043 
March Wing -1.232  0.392 (7) -0.318  0.600 (5) 0.112  0.619 (4) 0.214 
ICAM5     
January Blood 1.080  0.371 (10) 1.059  0.605 (9) 1.445  0.598 (7) 0.818 
January Wing 0.093  0.622 (7) -1.585  0.415 (6) -0.168  0.833 (5) 0.153 
March Wing -1.321  0.349 (7) -0.849  0.487 (5) 0.215  0.411 (4) 0.072 
TNFRSF21     
January Blood 0.302  0.320 (10)  1.092  0.198 (9) 0.404  0.449 (7) 0.176 
January Wing -0.363  0.344 (7) -0.050  0.420 (6) 0.182  0.615 (5) 0.692 
March Wing -0.729  0.579 (7) -0.643  0.390 (5) -0.279  0.617 (4) 0.841 
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Table 4. Selected comparisons of wing tissue across time and treatments for gene expression.    
P-values are based on one-way analysis of variance (ANOVA) for all genes of interest. The 
asterisk indicates statistical significance (p < 0.05). 
 
 NLRP10 CD200 ICAM5 TNFRSF21 
Jan. Pd vs. Mar. Pd 0.143 0.315 0.276 0.336 
Mar. Control vs. Mar. Pd 0.138 0.221 0.440 0.619 
Jan. Pd + Mel vs. Mar. Pd + Mel *< 0.0005 0.776 0.716 0.618 
Mar. Pd vs. Mar. Pd + Mel 0.185 0.636 0.151 0.151 
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Figure 1. WNS occurrence map, per county/district, (updated 04/23/2019) illustrating the origin 
of the fungus in the North America and the spread westward since 2006. 
https://www.whitenosesyndrome.org/static-spread-map/april-23-2019 
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Figure 2. Body temperature (ºC) can vary through torpor and arousal cycles. Torpor, a 
physiological depression, conserves stored energy. During an arousal period, body temperature 
will increase quickly, depleting fat reserves.  
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Figure 3. O2 consumption was measured via ExpeData
TM every second until at least three 
apneic/breathing cycles were accomplished. The apneic periods are shown as the relatively stable 
periods around baseline. The breathing periods are shown as the decrease in oxygen 
consumption, indicating the bat is utilizing oxygen present in the chamber. During apneic 
periods, the O2 concentration hovered around 20.95% oxygen; the breathing periods decreased 
the O2 concentration to approximately 20.26%. 
O
2  co
n
cen
tratio
n
 
 
Time (varied between bats, but generally averaged 14 hours) 
Breathing period Apneic period 
20.25% 
37 
Treatments
Control Pd Pd + mel
M
a
s
s
 L
o
s
s
 (
g
)
2
4
6
8
Treatments
Control Pd Pd + mel
A
ro
u
s
a
ls
2
4
6
8
10
12
p = 0.145
Treatments
Control Pd Pd + mel
O
2
 C
o
n
s
u
m
p
ti
o
n
 (
m
L
/m
in
)
0.000
0.005
0.010
0.015
0.020
Treatments
Control Pd Pd + mel
T
o
ta
l A
ro
u
s
a
l T
im
e
 (h
r)
0
10
20
30p = 0.089 p = 0.395
p = 0.340
 
 
 
Figure 4. Energetics data from big brown bats during hibernation, inoculated with Pd, with or 
without meloxicam (anti-inflammatory). P-values are based on a one-way analysis of variance 
(ANOVA). The torpid O2 consumption rates and total arousal time were highest in Pd + mel, 
which is consistent to a higher mass loss in this treatment. However, the among treatment values 
were not significantly different. 
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Figure 5. Mass loss (g) and total number of arousals had a positive relationship. The increase of 
arousals correlated with a lower overall mass loss for each individual.  
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Figure 6. Survival per treatment groups is displayed as percent survived, over 77 days. 
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Figure 7. NLRP10 expression data, per month, treatment, and sample type (wing or blood), are 
displayed as log10 gene expression relative to RPS8 (normalizing gene). Circles = control 
animals; squares = bats in the Pd treatment; triangles = bats in the Pd + mel treatment group.  
Closed symbols = wing samples; open circles = blood samples.  NLRP10 expression across 
treatment groups were not found to be different, except for January vs. March Pd + mel 
treatments. Blood samples also showed a higher NLRP10 expression than wing samples.   
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Figure 8. CD200 expression data, per month, treatment, and sample type (wing or blood), are 
displayed as log10 gene expression relative to RPS8 (normalizing gene). Circles = control 
animals; squares = bats in the Pd treatment; triangles = bats in the Pd + mel treatment group.  
Closed symbols = wing samples; open circles = blood samples. January wing tissue, across 
treatment groups, was different for CD200 expression. Expression in blood samples was also 
higher than wing samples. 
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Figure 9. ICAM5 expression data, per month, treatment, and sample type (wing or blood), are 
displayed as log10 gene expression relative to RPS8 (normalizing gene). Circles = control 
animals; squares = bats in the Pd treatment; triangles = bats in the Pd + mel treatment group.  
Closed symbols = wing samples; open circles = blood samples. There are no differences in 
ICAM5 expression across treatment groups; however, blood samples did show higher expression 
than wing samples.  
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Figure 10. TNFRSF21 expression data, per month, treatment, and sample type (wing or blood), 
are displayed as log10 gene expression relative to RPS8 (normalizing gene). Circles = control 
animals; squares = bats in the Pd treatment; triangles = bats in the Pd + mel treatment group.  
Closed symbols = wing samples; open circles = blood samples. The distribution of gene 
expression throughout treatment groups is fairly limited. Though the blood samples did contain 
higher expression compared to wing samples, those data are not significant. 
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